Kidney failure affects millions worldwide, and the number keeps rising. Each year, the global population of patients with end ...
Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...